Skip to main content

Animations

MJFF Publications

6611 - 6620 of 8654 Results
Title
Year
  • Year
  • 2020
  • 2024
  • 2022
  • 2013
  • 2022
  • 2023
  • 2021
  • 2021
  • 2017
  • 2022
  • Summary Details
    OPEN
    Title: A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-020-01750-3
    Citation Count: 56
  • Summary Details
    RESTRICTED
    Title: Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.4c00602
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28927
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25600
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Structure of the second phosphoubiquitin–binding site in parkin
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Association of women-specific health factors in the severity of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00524-x
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Video-based Parkinson’s disease assessments in a nationwide cohort of Fox Insight participants
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100094
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7
    Citation Count: 41
  • Summary Details
    OPEN
    Title: A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells11061018
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.